FDA Needs Better Way To Track Drug Safety, Study Says
The IOM's recommendations are not binding, and the FDA expressed some reservations about costs. Dr. Faden, who is also director
fda need well way track drug safety study say iom recommendation binding fda express reservation cost dr faden director